Quantifications reveal that healthy samples contain ≈5% of double positive GATA3+ & panCK+ cells, while DCIS has the highest percentage of GATA3+ & panCK+ cells at ≈50% compared to 45% for invasive carcinomas (Figure 3E). The gene discussed is GATA3; the disease is ductal breast carcinoma in situ.